CORPORATE GOVERNANCE STATEMENT    ANNUAL REPORT 2017      69
Committee
Purpose
Membership
Audit and Risk
Management
Committee
The committee’s objectives are to:
––
help the Board in relation to the reporting of financial information;
––
advise on the appropriate application and amendment of
accounting policies;
––
make evaluations and recommendations to the shareholders of the
Company regarding the external auditor;
––
recommend to the Board the remuneration of the external auditor for
shareholder approval as required in accordance with the Constitution;
––
provide a link between the Board and the external auditor
and management;
––
ensure that the Board, Directors and management are aware of
material risks facing the business; and
––
ensure the systems in place to identify, monitor and assess risk are
appropriate and operating effectively.
Gregory Fletcher – Chair
Geoffrey Raby
Qingchun Zhao
(appointed 17 May 2017)
Yuxiang Wu (resigned on 28 April 2017)
(minimum of three Non-Executive Directors,
a majority of whom are independent)
Health, Safety
and Environment
Committee
The committee assists the Board to:
––
fulfil its responsibilities in relation to the health, safety and environment
(collectively HSE) matters arising out of the activities of the Company;
––
consider, assess and monitor whether or not the Company has in
place the appropriate policies, standards, systems and resources
required to meet the Company’s HSE commitments; and
––
provide necessary focus and guidance on HSE matters across
the Company.
David Moult – Chair
(appointed 6 February 2018)
Geoffrey Raby
Fuqi Wang
Vincent O’Rourke AM (former Chair)
(resigned 30 January 2018)
(minimum of three Directors)
Nomination and
Remuneration
Committee
The committee assists the Board of the Company by making
recommendations in relation to:
––
Board composition and succession planning for the Board;
––
Director remuneration (subject to any shareholder approval that is
required in accordance with the Constitution and the ASX Listing
Rules) and remuneration arrangements for the Executive Committee
and any other person nominated as such by the committee from time
to time;
––
the public reporting of remuneration for Directors and the Company’s
Executive Committee;
––
the performance assessment of the Executive Committee;
––
designing company policy and regulations with regard to corporate
governance; and
––
diversity.
Xiyong Li – Chair
Cunliang Lai
Xiangqian Wu
(appointed 17 May 2017)
Helen Gillies
(appointed 6 February 2018)
William Randall
(resigned 9 November 2017)
(minimum of three Non-Executive Directors)
Strategy and
Development
Committee
The committee assists the Board in its oversight and review of the
Company’s strategic initiatives, including:
––
merger and acquisition proposals;
––
major capital markets transactions;
––
significant investment opportunities; and
––
proposals to dispose of significant Company assets.
Baocai Zhang – Chair
Qingchun Zhao
(appointed 17 May 2017)
Fuqi Wang
Xing Feng
(appointed 6 February 2018)
Yuxiang Wu
(resigned 28 April 2017)
Huaqiao Zhang
(resigned 30 January 2018)
(minimum of three Directors)
The primary role of the Strategy and Development Committee is to assist the Board in its oversight and review of the Company’s strategic
initiatives. The other standing Board committees referred to above are discussed further below under Principle 4 (Audit and Risk Management
Committee), Principle 7 (Health, Safety and Environment Committee) and Principle 8 (Remuneration and Nomination Committee). The Charters
of each of these standing Board committees are available within the Corporate Governance section of the Company’s website.